FRX

Fennec Pharmaceuticals Inc.

CA Healthcare Biotechnology

Latest week
10 Jul 2026
Close
14.500000
Fair value
10.548397
Next-week expectancy
Undecided 46.73%
Sharemaestro

FRX Chart Pack

Fennec Pharmaceuticals Inc.

Exchange
TOR
Latest week
10 Jul 2026
Close
14.500000
Fair value
10.548397
Next-week expectancy
Undecided 46.73%
Generated
17 Jul 2026 11:11
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, FRX rose 55.08%, moving from 9.35 to 14.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 6 of the last 12 weeks. Relative Strength is 13.28 and has improved across the 12-week window. Market Dynamics is 1.16 on the latest week. Next-week expectancy is undecided at 46.73% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
14.50
12-Week Change
55.08%
Trend Signal
Active
Next-Week Expectancy
Undecided 46.73%
Signal Weeks
6 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
13.28
Market Dynamics
1.16

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
14.50
12-Week Change
55.08%
Trend Signal
Active
Next-Week Expectancy
Undecided 46.73%
Signal Weeks
6 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
13.28
Market Dynamics
1.16

Over the latest 12 completed weeks ending 2026-07-10, FRX rose 55.08%, moving from 9.35 to 14.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 6 of the last 12 weeks. Relative Strength is 13.28 and has improved across the 12-week window. Market Dynamics is 1.16 on the latest week. Next-week expectancy is undecided at 46.73% based on similar historical setup states.

Industry Peers

Canada equities in Biotechnology

Stock Exchange Week Open High Low Close Change
MSCL Satellos Bioscience Inc. TOR 10 Jul 2026 10.95 14.15 10.86 13.53 23.56%
BCT BriaCell Therapeutics Corp. TOR 10 Jul 2026 4.82 5.64 4.82 5.58 15.77%
MBX Microbix Biosystems Inc. TOR 10 Jul 2026 0.30 0.32 0.30 0.32 6.67%
APS Aptose Biosciences Inc. TOR 3 Jul 2026 2.25 2.41 2.13 2.40 6.67%
HBP Helix BioPharma Corp. TOR 10 Jul 2026 1.43 1.45 1.25 1.44 0.70%
APLI Appili Therapeutics Inc. TOR 10 Jul 2026 0.02 0.02 0.01 0.02 0.00%
RVX Resverlogix Corp. TOR 10 Jul 2026 0.10 0.10 0.09 0.10 0.00%
EPRX Eupraxia Pharmaceuticals Inc. TOR 10 Jul 2026 9.68 10.05 9.02 9.46 -2.27%
SVA Sernova Biotherapeutics Inc TOR 10 Jul 2026 0.14 0.14 0.13 0.13 -7.14%
MDNA Medicenna Therapeutics Corp. TOR 10 Jul 2026 0.40 0.41 0.36 0.37 -7.50%
CSCI COSCIENS Biopharma Inc. TOR 10 Jul 2026 9.18 14.80 8.10 8.10 -11.76%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.